The specialised process underscores the demand for charging centers in strategic markets worldwide to enable efficient and timely cryogenic shipments. The approval of Ebvallo reflects the ...

APAP is the most common identifiable cause of ALF in children living in the United States and United Kingdom. [9] The PALF study has confirmed at least two clinical presentations; the first is an ...

Azacitidine is under clinical development by Bristol-Myers Squibb and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

Immunosuppressive treatment is considered for autoimmune, inflammatory and lymphoproliferative disorders that frequently develop in CVID. Bronchopulmonary hygiene measures and pulmonary ...